Searched for
INGEN CAPITAL
Smartkarma Research: Five things to know about China’s scandal-struck chip industry ‘Big Fund’Ding and Lu were key investment strategy decision-makers for the fund, known as the “Big Fund.” Since its establishment, the fund has built...- WRMS gets Euro 2.1 mn grant to provide solutions for yield guarantee to small farmersWRMS offers SecuFarm which is a sustainable farming solution for smallholders to provide them with farm level yield guarantee and an assure...
- NCLAT stays sale of Orchid to DhanukaIn response to a petition filed by Accord Life Spec Private Ltd, a company promoted by DMK MP Jagatrakshagan’s family members, the NCLAT st...
- Mandhana lenders move NCLT against buyout by US firmBankers say the US company failed to meet the terms of the pact as per agreed timeline.
- NCLT approves Dhanuka Lab’s Rs 1,116 crore plan to buy debt-hit Orchid PharmaA consortium of 24 banks has lent a total of over Rs 3,200 crore to the drug maker and the lenders will be taking a haircut of around 65%.
- Dhanuka Laboratories leads race for Orchid PharmaBesides Dhanuka, two other companies - Accord Life Spec and Covalent Laboratories - had bid for Chennai-based Orchid Pharma in a second rou...
- Unable to pay up? Top bidder to face penalty under new rule of insolvency regulation“After the amendment, Section 74 of the insolvency code prescribes stringent punishment to resolution applicant if it fails to implement a ...
- Divi’s, Gland, Fidelity enter race to buy Orchid PharmaThe move comes even as Divi’s Laboratories, Gland Celsus Bio Chemicals and Fidelity Trading Corporation have evinced interest to take over ...
- Ingen Capital sweetens Orchid Pharma offer, may acquire firmThe drug maker was among the 28 companies that the RBI mandated banks to refer to bankruptcy court by December 2017.
- Orchid Pharma faces liquidation as lenders reject resolution planOrchid Pharma was referred to the bankruptcy court by Lakshmi Vilas Bank after it failed to pay about Rs 3,500 crore to lenders.
- Thriveni Earthmovers bid rejected, Lanco Infratech may be headed for liquidationLanco Infratech, one of the first 12 stressed assets referred for insolvency resolution by the Reserve Bank of India in June last year, owe...
- Thriveni Earthmovers leads race for Lanco InfratechWith a debt of about Rs 45,000 crore, Lanco Infratech is one of the 12 stressed accounts identified by the Reserve Bank of India for resolu...
- Orchid Pharma’s lenders reject Union Quimico’s bidThe resolution professional who is in charge of the management of the Chennai-based company has set April 25 as the fresh date for submitti...
- Lenders want wilful defaulter tag for Lanco, ABG PromotersLanco is an infrastructure group with interests in roads and power.
- Seven firms ready to bid for Lanco InfratechLanco, holding company of several power and infrastructure projects, has debt of more than Rs 45,000 crore, taken from 29 financial credito...
- Orchid gets three final bids at par with liquidation valueThe company had to sell assets to rein in debt. In 2012, it sold its penicillin business to US drug maker Hospira for $200 million.
- UPL buys 26 per cent stake in Weather Risk ManagementThe collaboration will help UPL in providing farm services and precision farming solutions to farmers and several other value added service...
Load More
